Salud

Weight loss drug Zepbound gains ground in the US against Novo Nordisk’s Wegovy. Lilly has about 40% market share in the U.S., reaching 130,000 prescriptions

All doses of Eli Lilly’s weight-loss vaccine, Zepbound, and diabetes drug, Mounjaro, are now available, according to the US Food and Drug Administration. Mounjaro has

Drug maker Novo Nordisk said Thursday it has launched its weight-loss drug Wegovy in Australia, making the hugely popular drug available in 12 countries. Novo,

The US Food and Drug Administration (FDA) announced that it has approved Adaptimmune, a pioneering treatment for a rare type of soft tissue cancer that

French drugmaker Sanofi is to invest €1.3 billion in a new insulin production plant on the site of its existing Frankfurt plant, where it makes

Trial results show that Eli Lilly’s weight-loss drug Zepbound reduces the risk of hospitalisation, death and other outcomes for adults with obesity and a common

Drug maker Novo Nordisk said Thursday it has launched its weight-loss drug Wegovy in Australia, making the hugely popular drug available in 12 countries.

Smokers with type 2 diabetes taking Novo Nordisk According to a study of electronic health records released Monday, Ozempic participants had fewer tobacco-related health care

Pfizer, GSK and Moderna’s competition to supply new respiratory syncytial virus (RSV) vaccines is on Wall Street’s watch list as the companies will report their

Iowa on Monday banned abortions after six weeks of pregnancy, becoming the 22nd state to impose broad restrictions on abortion since the U.S. Supreme Court